Fig. 1: Elevated NRF2 increases xCT expression, system xc− activity, and downstream antioxidant capacity, detectable by [18F]FSPG.
From: Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography

a Schematic of system xc− with its natural substrates cystine and glutamate, and the radiotracer [18F]FSPG (structure shown in insert). b Protein expression of NRF2, xCT and NQO1 in a panel of NSCLC lines and corresponding KEAP1 mutations. Actin was used as a loading control. c Cystine consumption in NSCLC lines following media replenishment. Cys2, cystine. Intracellular glutamate (d) and GSH (e) in NSCLC lines. Flow cytometric measurement of total ROS levels using CellROX Green with representative histograms (f) and median fluorescent intensity (MFI; g) shown. h Intracellular retention of [18F]FSPG. i Correlation between intracellular GSH and intracellular [18F]FSPG accumulation. Broken lines represent the 95% confidence interval of the best-fit line. Data are presented as mean ± SD from n = 3 independent experiments. Comparisons were made across the mean of n = 4 cells per group (NRF2-high vs. NRF2-low) using an unpaired two-tailed Student’s t-test for (c–e, g–h). a created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license, https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en. For (b–e, g–i), source data are provided as a Source Data file.